Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lemaitre Vascular (LMAT) Acquisitions (2011 - 2026)

Lemaitre Vascular (LMAT) reported Acquisitions of $45000.0 for Q1 2026, up 2.27% year-over-year from $44000.0 in Q1 2025, and down 97.51% on a QoQ basis from $1.8 million in Q4 2025.

Lemaitre Vascular (LMAT) has 12 years of Acquisitions data on file, last reported at $45000.0 in Q1 2026.

  • Quarterly Acquisitions rose 2.27% year-over-year to $45000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.9 million (up 4218.18% YoY) and the FY2025 annual result came in at $1.9 million, changed N/A from the prior year.
  • Acquisitions slipped to $45000.0 in Q1 2026 per LMAT's latest filing, from $1.8 million in the prior quarter.
  • Across five years, Acquisitions topped out at $1.8 million in Q4 2025 and bottomed at $44000.0 in Q1 2025.
  • The 3-year median for Acquisitions is $161000.0 (2023), against an average of $406142.9.
  • Peak annual rise in Acquisitions reached 2.27% in 2026, while the deepest fall reached 2.27% in 2026.
  • Tracing LMAT's Acquisitions over 3 years: stood at $468000.0 in 2023, then jumped by 285.47% to $1.8 million in 2025, then plunged by 97.51% to $45000.0 in 2026.
  • Per Business Quant, the three latest LMAT Acquisitions figures stand at $45000.0 (Q1 2026), $1.8 million (Q4 2025), and $51000.0 (Q2 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Acquisitions (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn 528.20 Mn
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn -
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn 24.88 Mn
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn -
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn -
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn -
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn 18.96 Mn
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn -
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn -
10 Lemaitre Vascular 2.28 Bn 1.91 Bn 48.40 Mn 45,000.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 45,000.00
Dec 31, 2025 1.80 Mn
Jun 30, 2025 51,000.00
Mar 31, 2025 44,000.00
Sep 30, 2023 468,000.00
Jun 30, 2023 161,000.00
Mar 31, 2023 270,000.00
Sep 30, 2020 68,000.00
Jun 30, 2020 72.50 Mn
Mar 31, 2020 59,000.00
Dec 31, 2019 14.43 Mn
Sep 30, 2019 6.82 Mn
Dec 31, 2018 1.28 Mn
Dec 31, 2016 12.00 Mn
Jun 30, 2016 -14,000.00
Mar 31, 2016 2.38 Mn
Dec 31, 2015 139,000.00
Sep 30, 2015 158,000.00
Jun 30, 2015 1.13 Mn
Mar 31, 2015 138,000.00
Dec 31, 2014 982,000.00
Sep 30, 2014 5.38 Mn
Mar 31, 2014 193,000.00
Mar 31, 2013 111,000.00
Dec 31, 2012 4.35 Mn
Dec 31, 2011 510,000.00
Jun 30, 2011 370,000.00
Mar 31, 2011 271,000.00